Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Natural Health Trends | NHTC | Nov 22, 2024 | 5.63 | +0.54 |
Natural Resource Partners LP Unit | NRP | Nov 22, 2024 | 105.98 | -0.72 |
Nature Wood Group ADR | NWGL | Nov 22, 2024 | 1.41 | +0.84 |
Natures Miracle Holding | NMHI | Nov 22, 2024 | 2.31 | +5.00 |
Natures Sunshine Products | NATR | Nov 22, 2024 | 16.00 | +2.14 |
Natuzzi ADR | NTZ | Nov 22, 2024 | 4.33 | 0.00 |
NatWest ADR | NWG | Nov 22, 2024 | 9.90 | -3.04 |
Nauticus Robotics | KITT | Nov 22, 2024 | 1.06 | 0.00 |
Nautilus Biotechnology | NAUT | Nov 22, 2024 | 2.40 | +0.84 |
Navidea Biopharmaceuticals | NAVB | Nov 22, 2024 | 0.00 | 0.00 |
Navient | NAVI | Nov 22, 2024 | 15.37 | +2.95 |
Navigator Holdings | NVGS | Nov 22, 2024 | 16.32 | +2.51 |
Navios Maritime Partners LP Unit | NMM | Nov 22, 2024 | 51.80 | +0.82 |
Navitas Semiconductor | NVTS | Nov 22, 2024 | 2.42 | +19.80 |
Naya Biosciences | NAYA | Nov 22, 2024 | 0.86 | 0.00 |
Nayax | NYAX | Nov 22, 2024 | 28.69 | 0.00 |
NB Bancorp | NBBK | Nov 22, 2024 | 20.61 | +2.13 |
NBT Bancorp | NBTB | Nov 22, 2024 | 50.45 | +2.27 |
Ncino | NCNO | Nov 22, 2024 | 41.42 | +2.40 |
NCR | VYX | Nov 22, 2024 | 14.50 | -0.41 |
NCR Atleos When Issued | NATL | Nov 22, 2024 | 31.51 | +0.86 |
NCS Multistage | NCSM | Nov 22, 2024 | 23.01 | -2.95 |
Nebius Group | NBIS | Nov 22, 2024 | 23.49 | 0.00 |
Nektar Therapeutics | NKTR | Nov 22, 2024 | 1.05 | +3.96 |
Nelnet | NNI | Nov 22, 2024 | 107.93 | +1.90 |
Neogen | NEOG | Nov 22, 2024 | 14.98 | +2.74 |
NeoGenomics | NEO | Nov 22, 2024 | 16.39 | +6.50 |
Neonode | NEON | Nov 22, 2024 | 8.16 | +16.57 |
NeoVolta | NEOV | Nov 22, 2024 | 5.80 | +5.65 |
Nephros | NEPH | Nov 22, 2024 | 1.51 | +0.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.